Encompass Health’s (EHC) “Buy” Rating Reaffirmed at Stephens

Stephens reaffirmed their buy rating on shares of Encompass Health (AMEX:EHC) in a research report sent to investors on Friday. Stephens currently has a $55.00 price target on the stock.

A number of other research firms have also recently issued reports on EHC. Mizuho upgraded shares of Encompass Health from a neutral rating to a buy rating and set a $55.00 price objective on the stock in a research report on Thursday, November 2nd. Robert W. Baird restated a buy rating and issued a $59.00 price objective on shares of Encompass Health in a research report on Friday. Zacks Investment Research cut shares of Encompass Health from a hold rating to a sell rating in a research report on Wednesday, October 4th. Piper Jaffray Companies restated a hold rating and issued a $50.00 price objective on shares of Encompass Health in a research report on Sunday, September 17th. Finally, William Blair restated an outperform rating on shares of Encompass Health in a research report on Tuesday, November 21st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company. Encompass Health has a consensus rating of Hold and a consensus target price of $53.11.

Shares of Encompass Health (AMEX:EHC) traded up $0.95 during trading hours on Friday, reaching $51.46. 587,652 shares of the company were exchanged, compared to its average volume of 705,338. The stock has a market cap of $4,960.00, a PE ratio of 18.78, a PEG ratio of 1.70 and a beta of 0.54. Encompass Health has a one year low of $38.24 and a one year high of $52.58. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

Encompass Health (AMEX:EHC) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The firm had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. During the same quarter in the previous year, the company earned $0.65 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. equities research analysts predict that Encompass Health will post 2.72 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 1.94%. The ex-dividend date is Friday, December 29th. Encompass Health’s payout ratio is currently 36.50%.

In other Encompass Health news, Director Yvonne M. Curl acquired 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The shares were acquired at an average price of $45.95 per share, with a total value of $45,950.00. Following the completion of the purchase, the director now directly owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

A hedge fund recently bought a new stake in Encompass Health stock. Dalton Greiner Hartman Maher & Co. bought a new position in Encompass Health Corp (AMEX:EHC) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 331,823 shares of the company’s stock, valued at approximately $16,395,000. Dalton Greiner Hartman Maher & Co. owned approximately 0.34% of Encompass Health as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 93.18% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Encompass Health’s (EHC) “Buy” Rating Reaffirmed at Stephens” was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.thelincolnianonline.com/2018/01/13/encompass-healths-ehc-buy-rating-reaffirmed-at-stephens.html.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply